Reliq Health Technologies Inc V.RHT.H

Mingzhu ;

[1rockit]

Wow a $10.00 price target.. I'd say that's just a little to rich for me .. I'd be happy with 2 -3 dollars by the end of 2022 . I can clearly see that , especially with the new partner.. Cheers

[3burtc]

1rockit, if you use a very modest 16.6 x ARR you will have a price of $3.50 based on $40 million guidance for 2022. Next year $10.50/share based on $120 million ARR. This doesn't include any new contracts.gl.

[theinvestor22]

Recurring revenue companies tend to be valued based on run rates.  The $40M revenue run rate should be reached by mid-2022.

[theinvestor22]

This is transient, of course, but if you look at the current stated run rate of $24M, multiply by 10 and divide by about 205M shares, you get a value of about $1.17, which is just about what it's trading at.  Who knew? Of course, once the financials confirm stated fundamentals, that revenue multiple might just start to creep up, presumably boosted a lot once bigger contracts are

[lscfa]

Or 5x $40 mil 2022 revenues / 205 mil shs = $0.98    (Teladoc trading at 5x 2022 revenues)    

[SupremeNed]

min $10 by end of year your calculations mean nothing

[Jamesedgar1]

I'll take this as a positive post on fair value, if RHT's growth projections are legit and the market is forward looking, it bides well for the share price! GLTA....